Leidos (NYSE:LDOS) had its price objective upped by analysts at Morgan Stanley from $105.00 to $109.00 in a report issued on Friday, Benzinga reports. The brokerage presently has an “equal weight” rating on the aerospace company’s stock. Morgan Stanley’s price objective would suggest a potential upside of 2.17% from the stock’s current price.
Other equities research analysts also recently issued research reports about the company. Wells Fargo & Company began coverage on Leidos in a research report on Wednesday, May 12th. They issued an “overweight” rating and a $120.00 target price on the stock. Credit Suisse Group decreased their target price on shares of Leidos from $137.00 to $118.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 24th. Citigroup started coverage on shares of Leidos in a research note on Thursday, May 20th. They issued a “buy” rating on the stock. Bank of America increased their price objective on shares of Leidos from $120.00 to $125.00 and gave the stock a “buy” rating in a research report on Wednesday, March 3rd. Finally, Argus boosted their target price on Leidos from $100.00 to $118.00 and gave the company a “buy” rating in a research report on Wednesday, June 2nd. One investment analyst has rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $116.38.
Shares of LDOS opened at $106.68 on Friday. Leidos has a 12-month low of $79.15 and a 12-month high of $113.75. The stock has a market capitalization of $15.09 billion, a price-to-earnings ratio of 21.42, a P/E/G ratio of 1.57 and a beta of 0.90. The firm has a 50-day moving average price of $102.18. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.12 and a quick ratio of 1.02.
In other Leidos news, Director Gary Stephen May sold 500 shares of the stock in a transaction dated Thursday, May 13th. The stock was sold at an average price of $102.69, for a total value of $51,345.00. Following the sale, the director now owns 9,172 shares of the company’s stock, valued at approximately $941,872.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.57% of the company’s stock.
Several institutional investors and hedge funds have recently made changes to their positions in LDOS. Advisor Partners LLC increased its holdings in Leidos by 9.5% in the first quarter. Advisor Partners LLC now owns 3,244 shares of the aerospace company’s stock valued at $312,000 after buying an additional 281 shares during the last quarter. Schroder Investment Management Group increased its holdings in shares of Leidos by 54.5% in the 1st quarter. Schroder Investment Management Group now owns 597,647 shares of the aerospace company’s stock valued at $57,541,000 after acquiring an additional 210,765 shares during the last quarter. Fiduciary Trust Co. acquired a new stake in shares of Leidos during the 1st quarter worth about $314,000. Paloma Partners Management Co purchased a new stake in Leidos during the first quarter worth approximately $1,494,000. Finally, Millennium Management LLC boosted its holdings in Leidos by 16,745.5% in the first quarter. Millennium Management LLC now owns 394,664 shares of the aerospace company’s stock valued at $37,998,000 after purchasing an additional 397,035 shares in the last quarter. Institutional investors and hedge funds own 76.32% of the company’s stock.
Leidos Holdings, Inc provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. It operates through three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Featured Story: Futures Contract
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.